DePuy Hip Replacement Recall

Johnson & Johnson Failed To Take Action Prior To DePuy Hip Replacement Recall

by Staff Blogger | June 10th, 2014

The companies who design and manufacture the medical devices we use in healthcare today must thoroughly test their products before they are released to ensure they are safe. Companies are sometimes aware of problems with a product and fail to take corrective action, leading to defective medical device claims that can spawn civil litigation.

One such case stems from the DePuy hip replacement recall that was launched several years ago. The claims state the makers of the products, Johnson & Johnson, released two versions of the device—with testing only being conducted by the U.S. Food and Drug Administration. The other was approved for use based on the results of testing of the similar product.

Thousands of patients had the device implanted with many needing corrective surgery a short time later. It was determined the metals the product was made with were prematurely wearing, causing patients to suffer swelling, pain, and inflammation at the surgical site. Some patients even developed a condition known as Metalosis, in which the body absorbed toxic levels of heavy metal into the blood stream after it wore from the device inside the patient.

An article Yahoo News explains it has now been discovered that Johnson & Johnson was aware of certain faults with the product, but failed to take any action to correct the issues.

If a defective DePuy hip replacement device harmed you, you may be entitled to compensation. At the law firm of Ferrer, Poirot & Wansbrough, our team of defective medical product attorneys is available anytime to assess your situation and discuss your needs for legal representation. Call us anytime to talk about your case.

Federal Officials Investigating Johnson & Johnson’s Marketing Of Recalled Hip Device

by Staff Blogger | March 12th, 2013

March 12, 2013

In the wake of a massive recall of defective hip replacement devices manufactured by Johnson & Johnson (J&J) and its subsidiaries, federal officials are investigating whether the company participated in illegal marketing practices.

Several lawsuits filed against J&J allege they knew of problems with the DePuy ASR Hip Resurfacing System and the ASR XL Acetabular System, but continued marketing the products until 2009. At that time, the U.S. Food and Drug Administration began receiving reports of the devices’ failures and a recall was issued.

The primary reason for the DePuy Hip Replacement Recall seemed to be premature wear. The devices were supposed to last for roughly 10 to 20 years; however, one in eight patients reported needing the device replaced within five years. This premature wear also led to many patients suffering from a condition known as metallosis. This can occur when small pieces of metal are rubbed off the device by friction and then absorbed into the bloodstream. The condition can cause a patient to suffer numerous autoimmune problems.

According to the Star-Tribune, the current investigation into illegal marketing practices comes on the heels of the company paying $84.7 million in fines stemming from allegations of kickbacks being offered to doctors for using the company’s products.

The Dallas Personal Injury Lawyers with the law firm of Ferrer, Poirot & Wansbrough are happy to see action being taken to better protect patients from illegally marketed healthcare products.